Autonome neurokardiale Regulation bei depressiven Patienten, Effekte der Therapie mit dem Antidepressivum Nefazodon

84 137. Yeragani, V., Pohl, R., Balon, R., Ramesh, C., Glitz, D., Weinberg, P., Merlos, B. Effect of Imipramine Treatment on Heart Rate Variability Measures. Neuropsychobiology 26, 27-32 (1992). 138. Yeragani, V., Pohl, R., Berger, R., Balon, R., Ramesh, C., Glitz, D., Srinivasan, K., Weinberg, P. Decreased heart rate variability in panic disorder patients: a study of power spectral analysis of heart rate. Psychiatry. Res. 46, 89-103. (1992) 139. Zajecka, J. M. The effect of nefazodone on comorbid anxiety symptoms associated with depression: experience in family practice and psychiatric outpatient settings. J. Clin. Psychiatry. 57 (suppl.2), 10-14. (1996) 140. Zaudig, M., Wittchen, H. U., Saß, H. DSM-IV und ICD-10 Fallbuch. Hogrefe, Göttingen, Bern, Toronto, Seattle, 1. Aufl.. (2000) 141. Ziegler, D., Gries, F.A. Diagnostik und Therapie der kardiovaskulären autonomen diabetischen Neuropathie. Diab. Stoffw. 3, 22-31. (1994) 142. Ziegler, D., Laux, G., Dannehel, K., Spüler, M., Mühlen, H., Mayer, P., Gries, F. Assessment of cardiovascular autonomic function: age-related normal ranges and reproducibility of spectral analysis, vector analysis and standard tests of heart rate variation and blood pressure response. Diabet. Med. 9, 166-175. (1992) 143. Zorn, J. Nefazodon-neue Perspektiven in der Antidepressiven Therapie. Nervenarzt. 68, 7. (1997)